These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2873331)

  • 21. Chronic s.c. lisuride in Parkinson's disease--motor-performance and avoidance of psychiatric side effects.
    Bittkau S; Przuntek H
    J Neural Transm Suppl; 1988; 27():35-54. PubMed ID: 3165438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pergolide and lisuride for Parkinson's disease.
    Lieberman AN; Leibowitz M; Neophytides A; Kupersmith M; Mehl S; Kleinberg D; Serby M; Goldstein M
    Lancet; 1979 Nov; 2(8152):1129-30. PubMed ID: 91856
    [No Abstract]   [Full Text] [Related]  

  • 23. [Orally administered lisuride in the treatment of complex fluctuations of motion in Parkinson disease].
    Luquín MR; Obeso JA; Vaamonde J; Martínez Lage JM
    Neurologia; 1989 Sep; 4(7):229-32. PubMed ID: 2638588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopaminergic responsiveness to apomorphine after chronic treatment with subcutaneous lisuride infusion in Parkinson's disease.
    Vaamonde J; Luquin MR; Obeso JA
    Mov Disord; 1990; 5(3):260-2. PubMed ID: 2388647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term observation of chronic subcutaneous administration of lisuride in the treatment of motor fluctuations in Parkinson's disease.
    Heinz A; Suchy I; Klewin I; Kuhn W; Klotz P; Przuntek H
    J Neural Transm Park Dis Dement Sect; 1992; 4():291-301. PubMed ID: 1388700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of ergot derivative lisuride in Parkinson's disease.
    Suchy I; Horowski R
    Adv Neurol; 1984; 40():515-21. PubMed ID: 6695629
    [No Abstract]   [Full Text] [Related]  

  • 27. Lisuride in parkinsonism.
    Gopinathan G; Teräväinen H; Dambrosia JM; Ward CD; Sanes JN; Stuart WK; Evarts EV; Calne DB
    Neurology; 1981 Apr; 31(4):371-6. PubMed ID: 7194429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subcutaneous administration of lisuride in the treatment of complex motor fluctuations in Parkinson's disease.
    Obeso JA; Luquin MR; Vaamonde J; Martînez Lage JM
    J Neural Transm Suppl; 1988; 27():17-25. PubMed ID: 2969951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lisuride treatment in Parkinson's disease: clinical and pharmacokinetic studies.
    LeWitt PA; Burns RS; Calne DB
    Adv Neurol; 1983; 37():131-40. PubMed ID: 6344586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Lactation inhibition with various dosages of lisuride--prolactin secretion and effectiveness].
    Strahl HJ; Göretzlehner G; Strahl S; Kunkel S
    Zentralbl Gynakol; 1985; 107(5):300-3. PubMed ID: 4039514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bromocriptine and lisuride in Parkinson disease.
    Lieberman AN; Gopinathan G; Neophytides A; Leibowitz M; Walker R; Hiesiger E
    Ann Neurol; 1983 Jan; 13(1):44-7. PubMed ID: 6830164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lisuride in Parkinson's disease.
    Schachter M; Blackstock J; Dick JP; George RJ; Marsden CD; Parkes JD
    Lancet; 1979 Nov; 2(8152):1129. PubMed ID: 91855
    [No Abstract]   [Full Text] [Related]  

  • 33. Continuous dopaminergic stimulation in cranial dystonia.
    Micheli F; Fernandez Pardal MM; Gatto E; Paradiso G
    Clin Neuropharmacol; 1988 Jun; 11(3):241-9. PubMed ID: 3401858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subcutaneous infusion of apomorphine and lisuride in the treatment of parkinsonian on-off fluctuations.
    Stibe C; Lees A; Stern G
    Lancet; 1987 Apr; 1(8537):871. PubMed ID: 2882282
    [No Abstract]   [Full Text] [Related]  

  • 35. Lisuride in parkinsonism.
    Parkes JD; Schachter M; Marsden CD; Smith B; Wilson A
    Ann Neurol; 1981 Jan; 9(1):48-52. PubMed ID: 7212665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular effects of lisuride continuous intravenous infusion in fluctuating Parkinson's disease.
    Capria A; Attanasio A; Quatrana M; Cannata D; Fioravanti M; Stocchi F; Ruggieri S
    Clin Neuropharmacol; 1989 Aug; 12(4):331-8. PubMed ID: 2804995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Further studies with lisuride in Parkinson's disease.
    Lieberman AN; Goldstein M; Gopinathan G; Leibowitz M; Neophytides A; Walker R; Hiesiger E
    Eur Neurol; 1983; 22(2):119-23. PubMed ID: 6341071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Lisuride in the treatment of Parkinson syndrome].
    Filipová M; Roth B; Kás S; Macek Z; Rozsíval V; Karen P; Votavová M; Krejcová H
    Cesk Neurol Neurochir; 1987 Mar; 50(2):102-7. PubMed ID: 3581244
    [No Abstract]   [Full Text] [Related]  

  • 39. Lisuride, a dopamine agonist in the treatment of early Parkinson's disease.
    Rinne UK
    Neurology; 1989 Mar; 39(3):336-9. PubMed ID: 2927639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of chronic subcutaneous minipump infusion of lisuride upon locomotor activity of rats.
    Wachtel H; Rettig KJ; Löschmann PA
    J Neural Transm Suppl; 1988; 27():177-83. PubMed ID: 3165433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.